While there are some therapies for the most common forms of malaria, they’re usually only effective in one stage of the disease, leaving many patients at risk for a relapse. In one form of malaria, parasites can remain dormant in the liver for up to two years! But by isolating strains of parasites that are resistant to current treatments, scientists were able to develop a new target for malaria treatment that could work at multiple stages of the malaria life cycle. This is an important step in developing next-generation antimalarial drugs that can not only treat, but also prevent and block the spread of malaria. There’s still a lot of work to be done in the quest to eliminate the disease, but this new breakthrough is great news!
Pretty cool- the Novartis Malaria Initiative is a program that provides access to medicines, and over the last 10 years, they have delivered over 600 million treatments in over 60 countries- without profit! Their program aims to improve human health by creating long-term, sustainable access to medicines to those in developing countries.